Nektar Therapeutics - NKTR - stock price prediction, stock price target, analyst ratings from 12 analysts

Nektar Therapeutics has a share price target of US$ 144, revenue growth forecast of -24.2%, and profit growth estimate of -51.6% for FY26, based on top 12 analyst calls.